Final research reports made available on this website
Third parties have prepared final research reports for Pork CRC Ltd ACN 150 210 325 (Pork CRC), summarising the methodology, outcomes and potential applications of research projects that have been conducted via Pork CRC (Research Reports).
Those Research Reports are provided “as is” for the purpose of disseminating information to the public.
Any views, standards or recommendations expressed in those Research Reports do not necessarily reflect the position of Pork CRC. To the maximum extent permitted by law, and unless expressly stated otherwise, Pork CRC:
- makes no representation or warranty about the accuracy, reliability, currency, completeness or lawfulness of any Research Reports;
- does not exercise any editorial control or supervision over such Research Reports;
- cannot and does not endorse the content of any Research Reports; and
- suggests that users of the Research Reports exercise their own independent skill and judgment before relying on the content of any Research Reports and, where necessary or appropriate, seek independent professional advice which is relevant to their individual circumstances.
By continuing to use the Research Reports, and to the maximum extent permitted by law, you:
- accept the abovementioned terms upon which Research Reports are made available to you; and
- release Pork CRC and each of its officers, employees and agents from any claims or losses that you may suffer or incur in reliance upon or use of those Research Reports.
SubProgram 2A – Novel Disease Diagnostics
2A-101: Validation of data collection program for antibiotic use – Pat Mitchell, Rivalea – Confidential
2A-102: Real time detection of airborne pathogens – Marc Marenda, University of Melbourne – Summary Report
2A-103: Comparing mucosal and systematic immune response after live APP challenge – Huub Brouwers, NSW DPI – Summary Report
2A-104: Evaluation of diagnostic tests for Clostridium difficile – Tom Riley, University of Western Australia – Summary Report
2A-105: Reducing the risk of post-weaning E. coli diarrhoea using a potentially innovative feeding ingredient – John Pluske, Murdoch University – Summary Report
2A-106: A comprehensive risk factor analysis of E.coli disease in the piggery environment – Michael Ward, University of Sydney. Summary Report
2A-107: Antibiotic sensitivity of Haemophilus parasuis plus Actinobacillus pleuropneumoniae and other respiratory pathogens – Conni Turni, University of Qld – Summary Report
2A-108: Evaluation of oral fluid samples for herd health monitoring of pathogens and the immune response in pigs – Deborah Finlaison, EAMI, NSW DPI – Summary Report
2A-109: Development and validation of assays to measure gut health in order to identify risk factors for E.coli disease in weaner pigs – Alison Collins, EAMI, NSW DPI – Summary Report
2A-111: An investigation into the extent of occurrence of novel pathogenic Brachyspira species, including newly recognised agents of swine dysentery, in Australian pig herds – Dave Hampson, Murdoch University – Summary Report
2A-112: On-farm immunoassay test kit for inflammatory diseases to test the immune status of a herd – Jae Kim, DAFWA – Summary Report
2A-113: Enhancing the efficacy of vaccination through zinc supplementation – Rob Hewitt, CHM Summary Report
2A-114: Identifying, tracking and controlling swine dysentery in Australian pig herds – Dave Hampson, Murdoch University – Confidential
2A-115: Novel Porcine Actinobacillus species – diagnostic tools and pathogenicity evaluation – Conni Turni, University of Queensland – Summary Report
2A-117: Innovation Grant : Erysipelothrix rhusiopathiae Epi-Interface, a New Approach to the Management of Porcine Erysipelas. – Narelle Sales, NSW DPI – Summary Report
2A-118: Drinking water quality and its impacts on the health and performance of pigs – Louise Edwards, Ridley AgriProducts Summary Report
SubProgram 2B – Healthy, Robust Pig Genotypes
2B-101: Quantifying variation in environments within and across herds – Susanne Hermesch, AGBU – Summary Report
2B-102: Development of economic methodology to incorporate robustness in pig breeding programs – Susanne Hermesch, AGBU – Summary Report
2B-103: Estimation of genetic parameters for immune-competence and other physiological-priority traits for use in selection of disease resilience – Susanne Hermesch, AGBU – Summary Report
2B-104: Development of practical strategies to consider environmental sensitivity, survival and productivity in pig breeding programs – Susanne Hermesch, AGBU – Summary Report
2B-105: Genetic parameters for health, survival, immune competence, post-weaning growth and disease resilience of pigs – Susanne Hermesch, AGBU – Summary Report
2B-106: Simple tests for immune responsiveness of sires and the association with piglet mortality – Kim Bunter – AGBU – Summary Report
SubProgram 2C – Replacement of Antibiotics with Effective Integrated Health Strategies
2C-101 – Bacteriophages to control enterotoxigenic E. coli – Mary Barton, University of South Australia – Summary Report
2C-102: Strategies to quantitatively measure and reduce the load of Lawsonia in commercial herds – Alison Collins, NSW DPI – Summary Report Confidential
2C-103: Evaluating the efficacy of a Live APP vaccine with and without bacterin vaccines – Hugo Dunlop, Chris Richards & Associates – Cancelled
2C-105: Use of plant derived compounds to reduce post weaning antibiotic use – Eugeni Roura, University of Queensland Summary Report Confidential
2C-106: Targeting of APP cell surface receptors/peptides using phage display– Sharon Bishop-Hurley, CSIRO – Summary Report
2C-107: Investigation of oral rennin supplementation – Peter Cockcroft, University of Adelaide – Summary Report
2C-108: Passive immunisation for Oedema Disease – Andrew Morris, Chris Richards & Associates/University of Queensland – Summary Report
2C-109: Reducing sucker mortality through use of an innovative in-feed supplement – Cherie Collins, Rivalea – Summary Report
2C-110: Dietary manipulation of the pro-inflammatory cascade to minimise impacts on production and health indices in weaner pigs experimentally infected with an enterotoxigenic strain of E. coli – Jae Kim, DAFWA – Summary Report
2C-113: Bacteriophage-displayed peptides for the control of pathogens in swine – Sharon Bishop-Hurley, CSIRO – Summary Report Confidential
2C-114: High fibre diets and impact on gut health – John Pluske, Murdoch University – Confidential
2C-115: Establishing the underlying causes of pleurisy – Conni Turni, University of Queensland- Summary Report
2C-116: Live attenuated Actinobacillus pleuropneumoniae vaccine strains – Conni Turni, University of Queensland Summary Report Confidential
2C-117: Aerosol disinfection for control of APP15 – Peter McKenzie, Rivalea Report
2C-118: Using microencapsulated ingredients to enhance efficacy and improve production efficiency within an integrated health strategy – Rob Hewitt, CHM – Summary Report
2C-119: Alternative to vitamin E for the cost-effective maintenance of cellular antioxidant capacity in weaner pigs experimentally infected with enterotoxigenic strain of E. coli. – Jae Kim, DAFWA – Summary Report
2C-120: Lactoferrin as a new feed additive improves sow milk production and pig production– Bing Wang, CSU – Summary – Report
2C-121: A novel and safe fogging sanitiser for MRSA decolonisation and reduction of Actinobacillus pleuropneumoniae aerosol transmission between pigs. – Darren Trott, University of Adelaide – Summary – Report
2C-122: Alternatives to antibiotics for diarrhoea control, improved production and maintenance of intestinal health in weaner pigs – Alison Collins, NSW DPI – Confidential
2C-123: Self-assembled peptides as antimicrobial nanomaterials – Sharon Bishop-Hurley, CSIRO – Summary Report Confidential
2C-124: Evaluation of an atypical Brachyspira hyodysenteriae strain as a live vaccine to control swine dysentery – David Hampson, Murdoch University – Confidential
2C-125: Lauric acid, a potentially new feed additive for the Australian pork industry. – John Pluske – Murdoch University Summary Report
2C-126: Utilization of next generation sequencing for identifying Streptococcus suis clones responsible for recurrent outbreaks and identifying effective S. suis autogenous vaccine candidates. – Sam Abraham – Murdoch University – Summary – Report
2C-128: Protection from Escherichia coli-associated diseases after weaning in pigs using xenogeneic polyclonal antibodies specific for Escherichia coli fimbriae. – Cassandra Berry, Murdoch University – Confidential